The respective rapporteur Member States submitted the draft assessment reports to the Commission on 21 November 2003 (benalaxyl-M), on 9 March 2004 (spiromesifen), on 21 April 2004 (spirodiclofen), on 8 March 2005 (acequinocyl), on 14 March 2006 (proquinazid), on 22 August 2006 (aminopyralid), on 30 November 2006 (mandipropamid), on 12 January 2007 (novaluron) and on 10 September 2007 (ascorbic acid).
Asjaomased referentliikmesriigid esitasid komisjonile hindamisaruannete projektid 21. novembril 2003 (benalaksüül-M), 9. märtsil 2004 (spiromesifeen), 21. aprillil 2004 (spirodiklofeen), 8. märtsil 2005 (atsekinotsüül), 14. märtsil 2006 (prokinasiid), 22. augustil 2006 (aminopüraliid), 30. novembril 2006 (mandipropamiid), 12. jaanuaril 2007 (novaluroon) ja 10. septembril 2007 (askorbiinhape).